Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Income towards Parent Company (2019 - 2025)

Volitionrx filings provide 9 years of Income towards Parent Company readings, the most recent being $260595.0 for Q4 2025.

  • On a quarterly basis, Income towards Parent Company fell 49.54% to $260595.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.3 million, a 32.81% increase, with the full-year FY2025 number at $146302.0, down 49.58% from a year prior.
  • Income towards Parent Company hit $260595.0 in Q4 2025 for Volitionrx, up from -$31433.0 in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $516444.0 in Q4 2024 to a low of -$9.5 million in Q2 2023.
  • Median Income towards Parent Company over the past 5 years was $37528.5 (2021), compared with a mean of -$2.4 million.
  • Biggest five-year swings in Income towards Parent Company: skyrocketed 791.1% in 2022 and later crashed 12585.14% in 2023.
  • Volitionrx's Income towards Parent Company stood at $73088.0 in 2021, then grew by 28.74% to $94092.0 in 2022, then plummeted by 9380.53% to -$8.7 million in 2023, then soared by 105.91% to $516444.0 in 2024, then tumbled by 49.54% to $260595.0 in 2025.
  • The last three reported values for Income towards Parent Company were $260595.0 (Q4 2025), -$31433.0 (Q3 2025), and $29992.0 (Q2 2025) per Business Quant data.